BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32970346)

  • 1. What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
    Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N
    Cancer; 2020 Dec; 126(23):5022-5029. PubMed ID: 32970346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nurse scientists in cancer cooperative groups.
    Bruner DW; O'Mara A
    Semin Oncol Nurs; 2014 Feb; 30(1):4-10. PubMed ID: 24559774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCI Community Oncology Research Program: what every clinician needs to know.
    McCaskill-Stevens W; Lyss AP; Good M; Marsland T; Lilenbaum R
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Cancer Clinical Trials Network: recommendations from the Institute of Medicine.
    Nass SJ; Balogh E; Mendelsohn J
    Am J Ther; 2011 Sep; 18(5):382-91. PubMed ID: 21326081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners.
    Carlos RC; Sicks JD; Chang GJ; Lyss AP; Stewart TL; Sung L; Weaver KE
    J Am Coll Radiol; 2017 Dec; 14(12):1530-1537. PubMed ID: 29055605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Clinical Trials Network and the cooperative groups: The road not taken.
    Schilsky RL
    Cancer; 2020 Dec; 126(23):5008-5013. PubMed ID: 32970349
    [No Abstract]   [Full Text] [Related]  

  • 7. NCI, Cooperative Groups gear up for changes in clinical trials system: new policies initiated in response to institute of medicine report.
    Printz C
    Cancer; 2011 May; 117(10):2017-9. PubMed ID: 21523709
    [No Abstract]   [Full Text] [Related]  

  • 8. Cooperative Group Trials in the Community Setting.
    Lloyd Wade J; Petrelli NJ; McCaskill-Stevens W
    Semin Oncol; 2015 Oct; 42(5):686-92. PubMed ID: 26433550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.
    Scoggins JF; Ramsey SD
    J Natl Cancer Inst; 2010 Sep; 102(17):1371. PubMed ID: 20682918
    [No Abstract]   [Full Text] [Related]  

  • 10. Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.
    Sankaran H; Finnigan SR; McShane LM; Best AF; Seibel NL
    Cancer; 2022 Nov; 128(21):3843-3849. PubMed ID: 36089859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Cancer Care Delivery Research in the NCI Community Oncology Research Program.
    Geiger AM; O'Mara AM; McCaskill-Stevens WJ; Adjei B; Tuovenin P; Castro KM
    J Natl Cancer Inst; 2020 Jun; 112(6):557-561. PubMed ID: 31845965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights From Building a New National Cancer Institute Community Oncology Research Program Site.
    Saphner T; Thompson MA; Planton S; Singh M; Glandt N; Robinson L; DeBartolo J
    WMJ; 2016 Aug; 115(4):191-5. PubMed ID: 29099156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.
    Szczepanek CM; Hurley P; Good MJ; Denicoff A; Willenberg K; Dawson C; Kurbegov D
    J Oncol Pract; 2017 Jun; 13(6):395-400. PubMed ID: 28481681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why location matters: associations between county-level characteristics and availability of National Cancer Oncology Research Program and National Cancer Institute sites.
    Caston NE; Williams CP; Levitan EB; Griffin R; Azuero A; Wheeler SB; Rocque GB
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38745369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cooperative Groups: past and future.
    Comis RL
    Cancer Chemother Pharmacol; 1998; 42 Suppl():S85-7. PubMed ID: 9750036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCI Alliance for Nanotechnology in Cancer - from academic research to clinical interventions.
    Grodzinski P; Liu CH; Hartshorn CM; Morris SA; Russell LM
    Biomed Microdevices; 2019 Mar; 21(2):32. PubMed ID: 30904965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies.
    Deverka PA; Bangs R; Kreizenbeck K; Delaney DM; Hershman DL; Blanke CD; Ramsey SD
    J Natl Cancer Inst; 2018 Jun; 110(6):553-559. PubMed ID: 29684151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Globalization of Cooperative Groups.
    Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
    Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century".
    Bertagnolli MM; Canetta R; Nass SJ
    Oncologist; 2014 Nov; 19(11):1179-85. PubMed ID: 25326161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.